Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

Table of Contents

November 01, 2021; Volume 18,Issue 4

Editorial

  • You have access
    Cancer immunology and immunotherapy
    Xiubao Ren
    Cancer Biology & Medicine November 2021, 18 (4) 931-933; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0036
  • You have access
    Single-cell RNA sequencing reveals spatial heterogeneity and immune evasion of circulating tumor cells
    Yunfan Sun, Jian Zhou, Jia Fan and Xinrong Yang
    Cancer Biology & Medicine November 2021, 18 (4) 934-936; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0466
  • You have access
    Epithelial cells mimic immune cells: a novel path toward tumor immunotherapy
    Ruining Gong, Yan Huang, Xiaoxuan Wang, Xiaobing Chen, Zibin Tian and He Ren
    Cancer Biology & Medicine November 2021, 18 (4) 937-939; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0406
  • You have access
    The role of DLL1 in long-term vascular normalization and cancer immunotherapy
    Qiaozhen Wu and Yuhui Huang
    Cancer Biology & Medicine November 2021, 18 (4) 940-943; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0507
  • You have access
    Repurposing glucocorticoids as adjuvant reagents for immune checkpoint inhibitors in solid cancers
    Yingyan Yu
    Cancer Biology & Medicine November 2021, 18 (4) 944-948; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0491
  • You have access
    Multiplex imaging reveals the architecture of the tumor immune microenvironment
    Junlei Zhang, Jinyuan Song, Jianpeng Sheng, Xueli Bai and Tingbo Liang
    Cancer Biology & Medicine November 2021, 18 (4) 949-954; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0494

Review

  • You have access
    Personalized immunotherapy in cancer precision medicine
    Kazuma Kiyotani, Yujiro Toyoshima and Yusuke Nakamura
    Cancer Biology & Medicine November 2021, 18 (4) 955-965; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0032
  • You have access
    Cellular immunotherapy for hematological malignancy: recent progress and future perspectives
    Zhengli Xu and Xiaojun Huang
    Cancer Biology & Medicine November 2021, 18 (4) 966-980; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0801
  • You have access
    Insights into tertiary lymphoid structures in the solid tumor microenvironment: anti-tumor mechanism, functional regulation, and immunotherapeutic strategies
    Hua Zhao, Hao Wang, Qiuru Zhou and Xiubao Ren
    Cancer Biology & Medicine November 2021, 18 (4) 981-991; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0029
  • You have access
    Targeting myeloid-derived suppressor cells for cancer therapy
    Hongchao Tang, Hao Li and Zhijun Sun
    Cancer Biology & Medicine November 2021, 18 (4) 992-1009; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0806

Original Article

  • You have access
    Cyclophosphamide abrogates the expansion of CD4+Foxp3+ regulatory T cells and enhances the efficacy of bleomycin in the treatment of mouse B16-F10 melanomas
    Ping Li, Fengyang Chen, Jingbin Zheng, Yang Yang, Yuan Li, Yifei Wang and Xin Chen
    Cancer Biology & Medicine November 2021, 18 (4) 1010-1020; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0027
  • You have access
    EZH2 identifies the precursors of human natural killer cells with trained immunity
    Chen Zhang, Jie Yin, Jian Zheng, Jun Xiao, Jiajian Hu, Yudong Su, Kaichen Zhou, Yingchi Zhang, Xuzhen Zhang, Hong Zhang, Qian Sun, Yang Wang, Wenwen Yu, Feng Wei, Qiang Zhao, Long Li and Xiubao Ren
    Cancer Biology & Medicine November 2021, 18 (4) 1021-1039; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0791
  • You have access
    The commensal consortium of the gut microbiome is associated with favorable responses to anti-programmed death protein 1 (PD-1) therapy in thoracic neoplasms
    Huihui Yin, Lu Yang, Gongxin Peng, Ke Yang, Yuling Mi, Xingsheng Hu, Xuezhi Hao, Yuchen Jiao, Xiaobing Wang and Yan Wang
    Cancer Biology & Medicine November 2021, 18 (4) 1040-1052; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0450
  • You have access
    Residue substitution enhances the immunogenicity of neoepitopes from gastric cancers
    Huahui Yu, Jieyu Li, Yuan Yuan, Yu Chen, Jingwen Hong, Chunmei Ye, Wansong Lin, Huijing Chen, Zengqing Guo, Bo Li and Yunbin Ye
    Cancer Biology & Medicine November 2021, 18 (4) 1053-1065; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0022
  • You have access
    Culturing adequate CAR-T cells from less peripheral blood to treat B-cell malignancies
    Lu Han, Jian Zhou, Linlin Li, Keshu Zhou, Lingdi Zhao, Xinghu Zhu, Qingsong Yin, Yufu Li, Hongqin You, Jishuai Zhang, Yongping Song and Quanli Gao
    Cancer Biology & Medicine November 2021, 18 (4) 1066-1079; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0040
  • You have access
    Evaluation of 30 DNA damage response and 6 mismatch repair gene mutations as biomarkers for immunotherapy outcomes across multiple solid tumor types
    Zhe Gong, Yue Yang, Jieyun Zhang and Weijian Guo
    Cancer Biology & Medicine November 2021, 18 (4) 1080-1091; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0351
  • You have access
    Synergistic effects of AAGL and anti-PD-1 on hepatocellular carcinoma through lymphocyte recruitment to the liver
    Xiangdong Ye, Xueqing Wang, Wenhui Yu, Qing Yang, Yan Li, Yanxia Jin, Yanting Su, Jiaqi Song, Bo Xu and Hui Sun
    Cancer Biology & Medicine November 2021, 18 (4) 1092-1108; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0278
  • You have access
    Ferritin as a diagnostic, differential diagnostic, and prognostic marker for immune-related adverse events
    Weihong Zhang, Yuan Meng, Lin Yang, Meng Shen, Li Zhou, Runmei Li, Yang Wang, Weijiao Du, Yanjuan Xiong, Ying Han, Xinwei Zhang, Liang Liu and Xiubao Ren
    Cancer Biology & Medicine November 2021, 18 (4) 1109-1117; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0037
  • You have access
    Analysis of characteristics and predictive factors of immune checkpoint inhibitor-related adverse events
    Rilan Bai, Naifei Chen, Xiao Chen, Lingyu Li, Wei Song, Wei Li, Yuguang Zhao, Yongfei Zhang, Fujun Han, Zheng Lyu and Jiuwei Cui
    Cancer Biology & Medicine November 2021, 18 (4) 1118-1133; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0052
  • You have access
    The prognostic landscape of genes and infiltrating immune cells in cytokine induced killer cell treated-lung squamous cell carcinoma and adenocarcinoma
    Jian Wang, Fan Yang, Qian Sun, Ziqing Zeng, Min Liu, Wenwen Yu, Peng Zhang, Jinpu Yu, Lili Yang, Xinwei Zhang, Xiubao Ren and Feng Wei
    Cancer Biology & Medicine November 2021, 18 (4) 1134-1147; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0023
Back to top
PreviousNext

In this issue

Cancer Biology & Medicine: 18 (4)
Cancer Biology & Medicine
Vol. 18, Issue 4
1 Nov 2021
  • Table of Contents
  • Index by author

Submit

Sign up for alerts

Jump to

  • Editorial
  • Review
  • Original Article

  • Top Topics
  • Most Cited
  • Most Read
Loading
The advanced development of molecular targeted therapy for hepatocellular carcinoma
The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
Immunology and immunotherapy in breast cancer
Effects of menopausal hormone therapy-based on the role of estrogens, progestogens, and their metabolites in proliferation of breast cancer cells
Breast cancer screening and early diagnosis in Chinese women
Is adjuvant chemotherapy necessary for early gastric cancer?
Modulating microRNAs in cancer: next-generation therapies
Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma
Personalized immunotherapy in cancer precision medicine
Cellular immunotherapy for hematological malignancy: recent progress and future perspectives

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2023 Cancer Biology & Medicine

Powered by HighWire